Bovine dialyzable leukocyte extract modulates AP-1 DNA-binding activity and nuclear transcription factor expression in MCF-7 breast cancer cells

References

• Liu Y, Ludes-Meyers J, Zhang Y, et al. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Oncogene 2002; 21(50)7680–9
   PubMed Web of Science ®Google Scholar
• Lu C, Shen Q, DuPré E, et al. C-fos is critical for MCF-7 breast cancer growth. Oncogene 2005; 24: 6516–24
   PubMed Web of Science ®Google Scholar
• Suzukawa K, Colburn NH. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimmers. Oncogene 2002; 21: 2181–90
   PubMed Web of Science ®Google Scholar
• Huang C, Li J, Wei-Ya MA, Dong Z. JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-alpha but not by 12-O-tetradecanoylphorbol-13-acetate. J Biol Chem 1999; 274(42)29672–76
   PubMed Web of Science ®Google Scholar
• Degner SC, Kemp MQ, Bowden GB, Romagnolo DF. Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. J Nutr 2006; 136: 421–7
   PubMed Web of Science ®Google Scholar
• Shen G, Jeong WS, Hu R, Kong AN. Regulation of Nrf2, NF-kappaB, and AP-1 signaling pathways by chemopreventive agents. Antioxid Redox Signal 2005; 7: 1648–63
   PubMed Web of Science ®Google Scholar
• Verrecchia F, Tacheau C, Schorpp-Kistner M, et al. Induction of the AP-1 members c-Jun and Jun B by TGF-(/Smad suppresses early Smad-driven gene activation. Oncogene 2001; 20: 2205–11
   PubMed Web of Science ®Google Scholar
• Franco-Molina MA, Mendoza-Gamboa E, Miranda-Hernández D, et al. In vitro effects of bovine dialyzable leukocyte extract (bDLE) in cancer cells. Cytotherapy 2006; 8: 408–14
   PubMed Web of Science ®Google Scholar
• Franco-Molina MA, Mendoza-Gamboa E, Castillo-León L, Tamez-Guerra RS, Rodrìguez-Padilla C. Bovine dialyzable leukocyte extract protects against LPS-induced, murine endotoxic shock. Int Immunopharmacol 2004; 4: 1577–86
   PubMed Web of Science ®Google Scholar
• Mendoza-Gamboa E, Siwak DR, Tari AM. The HER/Grb2/Akt pathway regulates the DNA binding activity of AP-1 in breast cancer cells. Oncol Rep 2004; 12: 903–8
   PubMed Web of Science ®Google Scholar
• Siwak DR, Mendoza-Gamboa E, Tari AM. HER2/neu uses Akt to suppress retinoic acid response element binding activity in MDA-MB-453 breast cancer cells. Int J Oncol 2003; 23: 1739–45
   PubMed Web of Science ®Google Scholar
• Daschner PJ, Ciolino HP, Plouzek CA, Yeh GC. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells. Br Cancer Res Treat 1999; 53: 229–40
   PubMed Web of Science ®Google Scholar
• Smith LM, Wise SC, Hendricks DT, et al. C-Jun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 1999; 18: 6063–70
   PubMed Web of Science ®Google Scholar
• Langer S, Singer CF, Hudelist G, et al. Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters. Eur J Gynaecol Oncol 2006; 27: 345–52
   PubMed Web of Science ®Google Scholar
• Shaulianl E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001; 20: 2390–400
   PubMed Web of Science ®Google Scholar
• Ritke MK, JYalowich JC. Altered gene expression in human leukemia K562 cells selected for resistance to etoposide. Biochem Pharmacol 1993; 46: 2007–20
   PubMed Web of Science ®Google Scholar
• Duan L, Sterba K, Kolomeichuk S, et al. Inducible overexpression of c-Jun in MCF7 cells causes resistance to vinblastine via inhibition of drug-induced apoptosis and senescence at a step subsequent to mitotic arrest. Biochem Pharmacol 2007; 73: 481–90
   PubMed Web of Science ®Google Scholar
• Masuda ES, Naito Y, Tokumitsu H, et al. NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus. Mol Cell Biol 1995; 15: 2697–706
   PubMed Web of Science ®Google Scholar
• Degraffenried LA, Chandrasekar B, Friedrichs WE, et al. NF-(B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. Ann Oncol 2004; 15: 885–90
   PubMed Web of Science ®Google Scholar
• Yiu GK, Toser A. NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J Biol Chem 2006; 281: 12210–17
   PubMed Web of Science ®Google Scholar
• Hubé F, Chooniedass-Kothari S, Hamedani MK, et al. Identification of an octamer-binding site controlling the activity of the small breast epithelial mucin gene promoter. Front Biosci 2006; 11: 2483–95
   PubMed Web of Science ®Google Scholar
• Redell MS, Tweardy DJ. Targeting transcription factors for cancer therapy. Curr Pharm Des 2005; 11: 2873–87
   PubMed Web of Science ®Google Scholar